Impact of hematocrit on morbidity and mortality.

Impact of hematocrit on morbidity and mortality.

Item
http://www.wikidata.org/entity/Q33992468
Administration of pentoxifylline to improve anemia of hemodialysis patientsCardiovascular complications of diabetic kidney disease.Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysisEffect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Safety issues with intravenous iron products in the management of anemia in chronic kidney diseaseErythropoietin stimulating agents in the management of anemia of chronic kidney disease.Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devices.
P2860

Impact of hematocrit on morbidity and mortality.

Item
http://www.wikidata.org/entity/Q33992468
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Impact of hematocrit on morbidity and mortality.
@ast
Impact of hematocrit on morbidity and mortality.
@en
type
label
Impact of hematocrit on morbidity and mortality.
@ast
Impact of hematocrit on morbidity and mortality.
@en
prefLabel
Impact of hematocrit on morbidity and mortality.
@ast
Impact of hematocrit on morbidity and mortality.
@en
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Impact of hematocrit on morbidity and mortality.
@en
P2093
P304
P31
P433
P478
P577
P698